Global DNA methylation profiling reveals silencing of a secreted form of Epha7 in mouse and human germinal center B-cell lymphomas

D. W. Dawson, J. S. Hong, R. R. Shen, S. W. French, J. J. Troke, Y. Z. Wu, S. S. Chen, Dorina Gui, M. Regelson, Y. Marahrens, H. C. Morse, J. Said, C. Plass, M. A. Teitell

Research output: Contribution to journalArticle

33 Citations (Scopus)

Abstract

Most human lymphomas originate from transformed germinal center (GC) B lymphocytes. While activating mutations and translocations of MYC, BCL2 and BCL6 promote specific GC lymphoma subtypes, other genetic and epigenetic modifications that contribute to malignant progression in the GC remain poorly defined. Recently, aberrant expression of the TCL1 proto-oncogene was identified in major GC lymphoma subtypes. TCL1 transgenic mice offer unique models of both aggressive GC and marginal zone B-cell lymphomas, further supporting a role for TCL1 in B-cell transformation. Here, restriction landmark genomic scanning was employed to discover tumor-associated epigenetic alterations in malignant GC and marginal zone B-cells in TCL1 transgenic mice. Multiple genes were identified that underwent DNA hypermethylation and decreased expression in TCL1 transgenic tumors. Further, we identified a secreted isoform of EPHA7, a member of the Eph family of receptor tyrosine kinases that are able to influence tumor invasiveness, metastasis and neovascularization. EPHA7 was hypermethylated and repressed in both mouse and human GC B-cell non-Hodgkin lymphomas, with the potential to influence tumor progression and spread. These data provide the first set of hypermethylated genes with the potential to complement TCL1-mediated GC B-cell transformation and spread.

Original languageEnglish (US)
Pages (from-to)4243-4252
Number of pages10
JournalOncogene
Volume26
Issue number29
DOIs
StatePublished - Jun 21 2007

Fingerprint

Germinal Center
DNA Fingerprinting
B-Cell Lymphoma
DNA Methylation
B-Lymphocytes
Eph Family Receptors
Lymphoma
Epigenomics
Transgenic Mice
Neoplasms
Marginal Zone B-Cell Lymphoma
Proto-Oncogenes
Non-Hodgkin's Lymphoma
Genes
Protein Isoforms
Neoplasm Metastasis
Mutation
DNA

Keywords

  • B-cell lymphoma
  • DNA methylation
  • TCL1

ASJC Scopus subject areas

  • Molecular Biology
  • Genetics
  • Cancer Research

Cite this

Dawson, D. W., Hong, J. S., Shen, R. R., French, S. W., Troke, J. J., Wu, Y. Z., ... Teitell, M. A. (2007). Global DNA methylation profiling reveals silencing of a secreted form of Epha7 in mouse and human germinal center B-cell lymphomas. Oncogene, 26(29), 4243-4252. https://doi.org/10.1038/sj.onc.1210211

Global DNA methylation profiling reveals silencing of a secreted form of Epha7 in mouse and human germinal center B-cell lymphomas. / Dawson, D. W.; Hong, J. S.; Shen, R. R.; French, S. W.; Troke, J. J.; Wu, Y. Z.; Chen, S. S.; Gui, Dorina; Regelson, M.; Marahrens, Y.; Morse, H. C.; Said, J.; Plass, C.; Teitell, M. A.

In: Oncogene, Vol. 26, No. 29, 21.06.2007, p. 4243-4252.

Research output: Contribution to journalArticle

Dawson, DW, Hong, JS, Shen, RR, French, SW, Troke, JJ, Wu, YZ, Chen, SS, Gui, D, Regelson, M, Marahrens, Y, Morse, HC, Said, J, Plass, C & Teitell, MA 2007, 'Global DNA methylation profiling reveals silencing of a secreted form of Epha7 in mouse and human germinal center B-cell lymphomas', Oncogene, vol. 26, no. 29, pp. 4243-4252. https://doi.org/10.1038/sj.onc.1210211
Dawson, D. W. ; Hong, J. S. ; Shen, R. R. ; French, S. W. ; Troke, J. J. ; Wu, Y. Z. ; Chen, S. S. ; Gui, Dorina ; Regelson, M. ; Marahrens, Y. ; Morse, H. C. ; Said, J. ; Plass, C. ; Teitell, M. A. / Global DNA methylation profiling reveals silencing of a secreted form of Epha7 in mouse and human germinal center B-cell lymphomas. In: Oncogene. 2007 ; Vol. 26, No. 29. pp. 4243-4252.
@article{aa6d20dfb45f4d1aab2b7413703d0284,
title = "Global DNA methylation profiling reveals silencing of a secreted form of Epha7 in mouse and human germinal center B-cell lymphomas",
abstract = "Most human lymphomas originate from transformed germinal center (GC) B lymphocytes. While activating mutations and translocations of MYC, BCL2 and BCL6 promote specific GC lymphoma subtypes, other genetic and epigenetic modifications that contribute to malignant progression in the GC remain poorly defined. Recently, aberrant expression of the TCL1 proto-oncogene was identified in major GC lymphoma subtypes. TCL1 transgenic mice offer unique models of both aggressive GC and marginal zone B-cell lymphomas, further supporting a role for TCL1 in B-cell transformation. Here, restriction landmark genomic scanning was employed to discover tumor-associated epigenetic alterations in malignant GC and marginal zone B-cells in TCL1 transgenic mice. Multiple genes were identified that underwent DNA hypermethylation and decreased expression in TCL1 transgenic tumors. Further, we identified a secreted isoform of EPHA7, a member of the Eph family of receptor tyrosine kinases that are able to influence tumor invasiveness, metastasis and neovascularization. EPHA7 was hypermethylated and repressed in both mouse and human GC B-cell non-Hodgkin lymphomas, with the potential to influence tumor progression and spread. These data provide the first set of hypermethylated genes with the potential to complement TCL1-mediated GC B-cell transformation and spread.",
keywords = "B-cell lymphoma, DNA methylation, TCL1",
author = "Dawson, {D. W.} and Hong, {J. S.} and Shen, {R. R.} and French, {S. W.} and Troke, {J. J.} and Wu, {Y. Z.} and Chen, {S. S.} and Dorina Gui and M. Regelson and Y. Marahrens and Morse, {H. C.} and J. Said and C. Plass and Teitell, {M. A.}",
year = "2007",
month = "6",
day = "21",
doi = "10.1038/sj.onc.1210211",
language = "English (US)",
volume = "26",
pages = "4243--4252",
journal = "Oncogene",
issn = "0950-9232",
publisher = "Nature Publishing Group",
number = "29",

}

TY - JOUR

T1 - Global DNA methylation profiling reveals silencing of a secreted form of Epha7 in mouse and human germinal center B-cell lymphomas

AU - Dawson, D. W.

AU - Hong, J. S.

AU - Shen, R. R.

AU - French, S. W.

AU - Troke, J. J.

AU - Wu, Y. Z.

AU - Chen, S. S.

AU - Gui, Dorina

AU - Regelson, M.

AU - Marahrens, Y.

AU - Morse, H. C.

AU - Said, J.

AU - Plass, C.

AU - Teitell, M. A.

PY - 2007/6/21

Y1 - 2007/6/21

N2 - Most human lymphomas originate from transformed germinal center (GC) B lymphocytes. While activating mutations and translocations of MYC, BCL2 and BCL6 promote specific GC lymphoma subtypes, other genetic and epigenetic modifications that contribute to malignant progression in the GC remain poorly defined. Recently, aberrant expression of the TCL1 proto-oncogene was identified in major GC lymphoma subtypes. TCL1 transgenic mice offer unique models of both aggressive GC and marginal zone B-cell lymphomas, further supporting a role for TCL1 in B-cell transformation. Here, restriction landmark genomic scanning was employed to discover tumor-associated epigenetic alterations in malignant GC and marginal zone B-cells in TCL1 transgenic mice. Multiple genes were identified that underwent DNA hypermethylation and decreased expression in TCL1 transgenic tumors. Further, we identified a secreted isoform of EPHA7, a member of the Eph family of receptor tyrosine kinases that are able to influence tumor invasiveness, metastasis and neovascularization. EPHA7 was hypermethylated and repressed in both mouse and human GC B-cell non-Hodgkin lymphomas, with the potential to influence tumor progression and spread. These data provide the first set of hypermethylated genes with the potential to complement TCL1-mediated GC B-cell transformation and spread.

AB - Most human lymphomas originate from transformed germinal center (GC) B lymphocytes. While activating mutations and translocations of MYC, BCL2 and BCL6 promote specific GC lymphoma subtypes, other genetic and epigenetic modifications that contribute to malignant progression in the GC remain poorly defined. Recently, aberrant expression of the TCL1 proto-oncogene was identified in major GC lymphoma subtypes. TCL1 transgenic mice offer unique models of both aggressive GC and marginal zone B-cell lymphomas, further supporting a role for TCL1 in B-cell transformation. Here, restriction landmark genomic scanning was employed to discover tumor-associated epigenetic alterations in malignant GC and marginal zone B-cells in TCL1 transgenic mice. Multiple genes were identified that underwent DNA hypermethylation and decreased expression in TCL1 transgenic tumors. Further, we identified a secreted isoform of EPHA7, a member of the Eph family of receptor tyrosine kinases that are able to influence tumor invasiveness, metastasis and neovascularization. EPHA7 was hypermethylated and repressed in both mouse and human GC B-cell non-Hodgkin lymphomas, with the potential to influence tumor progression and spread. These data provide the first set of hypermethylated genes with the potential to complement TCL1-mediated GC B-cell transformation and spread.

KW - B-cell lymphoma

KW - DNA methylation

KW - TCL1

UR - http://www.scopus.com/inward/record.url?scp=34250813682&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34250813682&partnerID=8YFLogxK

U2 - 10.1038/sj.onc.1210211

DO - 10.1038/sj.onc.1210211

M3 - Article

C2 - 17260020

AN - SCOPUS:34250813682

VL - 26

SP - 4243

EP - 4252

JO - Oncogene

JF - Oncogene

SN - 0950-9232

IS - 29

ER -